Home/ Stocks/ GPCR

Structure Therapeutics Inc. American Depositary Shares

GPCR XNAS

$53.14 +1.12 (+2.13%) ▲ 15-min delayed

Open

$53.80

High

$54.80

Low

$50.83

Volume

329.5K

Market Cap

$3.74B

About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 233 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-75,968,000	$-0.35
FY 2025	$0	$-141,202,000	$-0.80
Q3 2025	$0	$-65,712,000	$-0.37
Q2 2025	$0	$-61,661,000	$-0.36

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for GPCR yet. Check out our latest market news or earnings calendar.

Get GPCR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Structure Therapeutics Inc. American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.